← All companiesBy market cap
✕NegativeTier 1

Gujarat Ambuja Exports LtdNSE:GAEL

Food Products · ₹7,239 Cr market cap · covered for 1 quarter since Q1 2027

Current view Q1 2027

India's largest maize processor, milling corn into starch and sweeteners, it earns the crush spread. Growth came from raw-material prices getting cheaper while product prices stayed stable, not from strategy.

Latest exchange filings last 5 · 5 after Q1 2027

Exchange filings, with the company's own one-line summary, read off the same page as the figures. Screener publishes only the most recent few, so this is the last 5 — not everything filed since your note, and a quiet-looking list is not proof of a quiet quarter. A filing is marked new when it is dated after the end of the quarter your note covers. Not scored, and not a judgement — a routine repayment notice and a takeover sit in the same list.

AI concall report · Q1 2027

The full earnings-call read behind this view — what management promised, what they delivered, and the earning trigger.

✨ Read the report ↗

Growth Q1 2027

Metric This year vs lastYoY · vs Q1 2026 vs the quarter beforeQoQ, sequential · vs Q4 2026 3-year yearly average3Y CAGR · compounded 5-year yearly average5Y CAGR · compounded
Sales▲ +23.5%+8.7%+5.3%+4.0%
Operating profit▲ +141.7%+19.0%+1.3%+0.3%
EPS▲ +171.1%+30.5%−2.7%−2.1%
PAT▲ +172.3%+31.1%——

Tinted rows drive the Tier. Tier = the weaker of YoY Sales and YoY PAT growth. Here the weaker is Sales at +23.5%, which is ≥ 20% → Tier 1.

QoQ is sequential, not a trend. For most Indian companies the March quarter is seasonally the largest, so a June-quarter fall against it is a calendar effect. Only the YoY column feeds the Tier.

Multibagger potential Weak34/100

Earnings are shrinking, not growing. Profit per share fell 3% a year over the window measured. Nothing compounds from here until that turns, whatever the price does.

No forward view — earnings are not compounding, so there is nothing to project.

The Hope Tradebuyers paying more for earnings that are not growing⚠ inflection
Is it cheap right now?earnings are not growing — a low multiple here is not a discount 0/25
Has the market paid for this growth yet?ΔMultiple ×1.00 a year (×1.01 over 3 years) — multiple flat 6/15
Is the growth real, or flattered?EPS fell year-on-year; QoQ holding 10/30
What does it earn on its own money?earns 13% on its own book — fair 5/10
Is the price trend agreeing?above 40W, below the shorter EMAs 13/20
Price vs its book value 2.2×P/B — ₹72 of book value per share
Price over the last year ×0.98earnings ×0.97, price-tag ×1.00

Multiple moved without the earnings — the return sits in sentiment.

How this is calculated

Band capped: earnings are not growing over the measured window.

Growth rate used: -2.7% — the weakest of EPS / Sales / Op-profit from 3-year EPS CAGR. Latest quarter reads 60%.

How it compares with its rivals Food Products · 6 of 40 listed

It earns 12% on its capital, fourth of 6, and it is the fourth most expensive of the 6 shown.

Company PriceP/ESizeROCE Profitlast qtr Saleslast qtr
Guj. Ambuja Exp ₹160 17.5× ₹7,346 Cr 12.5% +171.9% +23.5%
L T Foods ₹417 22.6× ₹14,472 Cr 17.6% +8.9% +27.9%
KRBL ₹392 11.8× ₹8,966 Cr 15.2% +73.2% −5.6%
TruAlt Bioenergy ₹427 23.4× ₹3,664 Cr 10.4% +1108.3% +106.3%
Kaveri Seed Co. ₹703 14.5× ₹3,616 Cr 18.8% −14.2% −13.5%
Sanstar ₹115 52.5× ₹2,311 Cr 5.7% +2808.8% +21.5%

Screener's own peer group, from the request already made for the industry P/E. It serves the industry's largest names by market cap, not companies of a similar size, so treat this as context rather than a like-for-like table; this company is always shown. On a phone the price, size and sales columns are dropped rather than pushed off the edge. Not part of the score.

Business quality to Jun 2026

Are the margins widening? yes — widening, and steadily operating margin 9% → 15% over 3 years
Did the profit turn into cash? most of it arrived as cash 69% last year, 81% over three · free cash flow −₹153 cr, positive in 4 of 5 years
Is the growth borrowed? lightly borrowed ₹441 cr — 0.13× its own equity (was 0.08×)
Is it being collected? collection is steady 28 days to collect, down 0 in a year · cash cycle 84 days
Who has been buying? the promoters have held steady promoters 63.8%, 63.8% → 63.8% over 2.8 years · FIIs 3.0% (+0.8) · DIIs 0.7% (+0.5) · shareholders 82,358 → 1,07,147
What does it earn on its capital? earns a fair return on its capital ROCE 12.5% · ROE 9.7%

Fetched from the filings, not typed — and deliberately not part of the score. These are the questions the score cannot ask: it reads growth, price and trend, so a company can score well while its profit never becomes cash. Weigh these beside the note, not against the number.

Screener's own checklist not mine, not the score

Against it

  • The company has delivered a poor sales growth of 4.01% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.
  • Dividend payout has been low at 3.06% of profits over last 3 years

Generated by screener.in from a fixed checklist — not written by me and not an input to the score. It is here as a second machine opinion to weigh against the note; where it disagrees with the view above, the note is the considered one.